Ankur Vyas
Interventional Cardiology · Cedar Rapids, IANPI 1528222320
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Abiomed at 52.7% of the total. 2025 is the largest year on record at $111, more than ten times the $2 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in IA, where the typical reported total is $3,872.
Across 8 payments — averaging $21.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$91
- Shockwave Medical, Inc$19
- Edwards Lifesciences$19
- Medtronic$17
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$14
- Philips North America LLC$13
What the payments were for
- Food & beverage$173100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 2 | $91 |
| Shockwave Medical, Inc | 1 | $19 |
| Edwards Lifesciences | 1 | $19 |
| Medtronic | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $14 |
| Philips North America LLC | 1 | $13 |
How this compares
$173 in reported general payments places this provider in the 5th percentile of 64 interventional cardiology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 410 | $381,478 |
| EliquisApixaban | 366 | $354,657 |
| Repatha SureclickEvolocumab | 187 | $116,190 |
| EntrestoSacubitril/Valsartan | 51 | $45,969 |
| JardianceEmpagliflozin | 21 | $22,520 |
| Praluent PenAlirocumab | 43 | $20,362 |
| BrilintaTicagrelor | 21 | $11,526 |
| Metoprolol Succinate | 1,049 | $10,855 |
| Repatha SyringeEvolocumab | 13 | $7,215 |
| Rosuvastatin Calcium | 487 | $5,658 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 14 | $4,809 |
| Atorvastatin Calcium | 565 | $4,591 |
| Potassium Chloride | 166 | $4,526 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 181 | $3,517 |
| Bumetanide | 51 | $3,070 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Cedar Rapids
- Ryan HollenbeckCedar Rapids$19K
- Antony AnandarajCedar Rapids$5K
- Subhi Abu HalawaCedar Rapids$2K
- Richard KettelkampCedar Rapids$2K
- Hisham WagdyCedar Rapids$439
- Nicolas ShammasDavenport$808K
- Eric DippelDavenport$100K
- Atul ChawlaDes Moines$78K
- Magdi GhaliWest Des Moines$64K
- David McAllisterDes Moines$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.